EC probes India's GVK Bio for data integrity spanning six years
This article was originally published in Scrip
Executive Summary
Hyderabad-based GVK BioSciences, one of India's well-known CROs, is the latest to face extensive international regulatory investigations on alleged charges of serious GCP non-compliance and concerns about its bioequivalence studies, including data used to support marketing authorization applications of generic medicines.